Biotech

All Articles

Acepodia, Pfizer click on all together for chemistry-based cell therapy

.Phone it a case of excellent chemistry: Acepodia, a biotech based upon Nobel Prize-winning science,...

Praxis epilepsy drug decreases seizures in phase 2 litigation

.Practice Preciseness Medicines has scored another midphase gain in epilepsy this year, along with i...

Three officers resign as Dyne articles combined information for DMD prospect

.After getting away a professional hold many years back, Dyne Therapeutics has revealed new phase 1/...

Arrowhead fires off stage 3 data in uncommon metabolic illness in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has presented its give before a possible showdown along with Ionis, posti...

Pfizer, Valneva present lyme condition go efficient for 2nd booster

.Pfizer as well as Valneva might possess about two more years to hang around before they help make t...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Shop with Michelle Benz on the Future of Biotech.

.Allow's study a discussion with Ayla Ellison, Brutal Biotech Managing Editor as well as Michelle Be...

New records demonstrate how Bayer's asundexian neglected to prevent strokes

.Bayer put on hold the period 3 trial for its element XIa inhibitor asundexian late in 2013 after th...

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS trials

.Sanofi is actually still set on taking its own numerous sclerosis (MS) med tolebrutinib to the FDA,...

Galapagos' stockpile as fund presents intent to shape its own progression

.Galapagos is actually coming under extra tension coming from financiers. Having actually created a ...

Cell- centered Sana gathers initial CSO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of considerable management hirings, shooting...